California-based Blüm Holdings Inc. (OTCQB: BLMH) reported a net loss of $3.3 million for its third quarter of the year, down ...
Management’s been trying to prioritize bulk concentrate manufacturing and higher-margin verticals despite lower overall ...
The clinical-stage biopharmaceutical company said it has enough cash to reach the milestones it laid out for 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback